South Africa’s Aspen sells Australian prescription portfolio to MylanAcquisitions, Australia, Business, OTC, Prescription Drugs, South AfricaAspen Pharmacare said Mylan NV exercised an option to buy the South African drugmaker’s portfolio of prescription and over-the-counter products in Australia for 188 million Australian dollars ($130 million). Read more May 20, 2019/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2019-05-20 04:17:512019-05-22 13:03:48South Africa’s Aspen sells Australian prescription portfolio to Mylan